drug protocol number

NRG-HN002

drug sponsor

NRG Oncology King Faisal Specialist Hospital & Research Center

drug study

CISPLATIN (CISPLATYL )

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh)

drug status

Ongoing

drug phase